ACKR3 and depressive symptom measurement: Consistent with the in vitro results, CXCR7-siRNA attenuated the reduced in vivo reendothelialization capacity mediated by transplantation of XKS-pretreated EPCs from CAD patients with anxiety/depression (P < 0.01; Figures 6(d)–6(f)).